NextCure, Inc. (NXTC)
NASDAQ: NXTC · Real-Time Price · USD
12.34
-0.39 (-3.10%)
Dec 5, 2025, 4:00 PM EST - Market closed
NextCure Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
43
Market Cap
41.79M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
NXTC News
- 16 days ago - NextCure to Present at the Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 19 days ago - NextCure Announces Closing of $21.5 Million PIPE Financing in Advance of First Half 2026 Phase 1 POC Data Readouts - GlobeNewsWire
- 24 days ago - NextCure Announces $21.5 Million Private Placement of Common Stock Priced at the Market Under Nasdaq Rules - GlobeNewsWire
- 4 weeks ago - NextCure Provides Business Update and Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 7 weeks ago - NextCure and Simcere Zaiming Announce Expansion of Ongoing Phase 1 Trial of SIM0505 (CDH6 ADC) into the United States - GlobeNewsWire
- 3 months ago - NextCure to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 4 months ago - NextCure (NXTC) Q2 Loss Widens 71% - The Motley Fool
- 4 months ago - NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results - GlobeNewsWire